NASDAQ:MDSO - Medidata Solutions Stock Price, Price Target & More

Get Started

$75.97 -1.57 (-2.02 %)

(As of 05/22/2018 01:51 AM ET)

Previous Close$75.97

Today's Range$75.4850 - $78.01

52-Week Range$59.60 - $85.92

Volume730,949 shs

Average Volume628,755 shs

Market Capitalization$4.59 billion

P/E Ratio89.38

Dividend YieldN/A

Beta1.49

About Medidata Solutions (NASDAQ:MDSO)

Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner and ongoing support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force, as well as through relationships with contract research organizations (CROs) and other strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and CROs and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.

Receive MDSO News and Ratings via Email

Sign-up to receive the latest news and ratings for MDSO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Prepackaged software

Sub-IndustryHealth Care Technology

SectorMedical

SymbolNASDAQ:MDSO

CUSIP58471A10

Webwww.mdsol.com

Phone212-918-1800

Debt

Debt-to-Equity Ratio0.18

Current Ratio1.63

Quick Ratio1.63

Price-To-Earnings

Trailing P/E Ratio89.38

Forward P/E Ratio77.52

P/E Growth3.89

Sales & Book Value

Annual Sales$545.53 million

Price / Sales8.25

Cash Flow$1.5215 per share

Price / Cash49.93

Book Value$8.51 per share

Price / Book8.93

Profitability

EPS (Most Recent Fiscal Year)$0.85

Net Income$44.38 million

Net Margins7.96%

Return on Equity11.36%

Return on Assets5.59%

Miscellaneous

Employees1,680

Outstanding Shares59,220,000

Medidata Solutions (NASDAQ:MDSO) Frequently Asked Questions

What is Medidata Solutions' stock symbol?

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

How were Medidata Solutions' earnings last quarter?

Medidata Solutions (NASDAQ:MDSO) released its quarterly earnings results on Thursday, April, 19th. The company reported $0.40 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.35 by $0.05. The firm had revenue of $149.20 million for the quarter, compared to analyst estimates of $146.73 million. Medidata Solutions had a net margin of 7.96% and a return on equity of 11.36%. The business's revenue for the quarter was up 16.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.31 EPS. View Medidata Solutions' Earnings History.

When is Medidata Solutions' next earnings date?

Medidata Solutions is scheduled to release their next quarterly earnings announcement on Monday, July, 16th 2018. View Earnings Estimates for Medidata Solutions.

What price target have analysts set for MDSO?

13 Wall Street analysts have issued 1-year price targets for Medidata Solutions' stock. Their forecasts range from $78.00 to $95.00. On average, they anticipate Medidata Solutions' share price to reach $84.4615 in the next twelve months. View Analyst Ratings for Medidata Solutions.

Who are some of Medidata Solutions' key competitors?

Some companies that are related to Medidata Solutions include Splunk (SPLK), Check Point Software Technologies (CHKP), Shopify (SHOP), CA Technologies (CA), Citrix Systems (CTXS), Mobileye (MBBYF), Ansys (ANSS), Symantec (SYMC), Synopsys (SNPS), Take-Two Interactive (TTWO), SS&C Technologies (SSNC), Dropbox (DBX), Cadence Design Systems (CDNS), Ubisoft (UBSFY) and Veeva Systems (VEEV).

Who are Medidata Solutions' key executives?

Medidata Solutions' management team includes the folowing people:

Mr. Tarek A. Sherif, Co-Founder, Chairman and Chief Exec. Officer (Age 56)
Mr. Glen M. De Vries, Co-Founder, Pres & Director (Age 46)
Dr. Rouven Bergmann, CFO & Chief Accounting Officer (Age 45)
Mr. Michael I. Otner, Exec. VP, Gen. Counsel & Sec. (Age 47)
Ms. Julie Iskow, Exec. VP of Product Devel. & CTO

Has Medidata Solutions been receiving favorable news coverage?

News articles about MDSO stock have trended somewhat positive this week, Accern reports. The research group rates the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Medidata Solutions earned a daily sentiment score of 0.00 on Accern's scale. They also assigned press coverage about the company an impact score of 47.19 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are Medidata Solutions' major shareholders?

Medidata Solutions' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Champlain Investment Partners LLC (3.63%), American Century Companies Inc. (2.44%), Global Thematic Partners LLC (2.34%), Disciplined Growth Investors Inc. MN (1.57%), Eagle Asset Management Inc. (1.49%) and Stephens Investment Management Group LLC (1.40%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Eileen Schloss, Michael I Otner, Michael L Capone, Michael Pray, Neil M Kurtz, Robert Taylor, Rouven Bergmann, Steven Isaac Hirschfeld, Tarek Sherif and Vries Glen Michael De. View Institutional Ownership Trends for Medidata Solutions.

Which major investors are selling Medidata Solutions stock?

MDSO stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Russell Investments Group Ltd., Global Thematic Partners LLC, Carillon Tower Advisers Inc., PNC Financial Services Group Inc., Millennium Management LLC, Stevens Capital Management LP and Loomis Sayles & Co. L P. Company insiders that have sold Medidata Solutions company stock in the last year include Carlos Dominguez, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Insider Buying and Selling for Medidata Solutions.

Which major investors are buying Medidata Solutions stock?

MDSO stock was bought by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Echo Street Capital Management LLC, Rockefeller Capital Management L.P., Champlain Investment Partners LLC, Massachusetts Financial Services Co. MA, Zevenbergen Capital Investments LLC, Disciplined Growth Investors Inc. MN and Eaton Vance Management. View Insider Buying and Selling for Medidata Solutions.

How do I buy shares of Medidata Solutions?

Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medidata Solutions' stock price today?

One share of MDSO stock can currently be purchased for approximately $75.97.

How big of a company is Medidata Solutions?

Medidata Solutions has a market capitalization of $4.59 billion and generates $545.53 million in revenue each year. The company earns $44.38 million in net income (profit) each year or $0.85 on an earnings per share basis. Medidata Solutions employs 1,680 workers across the globe.

How can I contact Medidata Solutions?

Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]

MarketBeat Community Rating for Medidata Solutions (MDSO)

Community Ranking:		3.0 out of 5 ( )
Outperform Votes:		361 (Vote Outperform)
Underperform Votes:		242 (Vote Underperform)
Total Votes:		603

MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe MDSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDSO will underperform the S&P 500 over the long term. You may vote once every thirty days.

Medidata Solutions (NASDAQ:MDSO) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

13 Wall Street analysts have issued ratings and price targets for Medidata Solutions in the last 12 months. Their average twelve-month price target is $84.4615, suggesting that the stock has a possible upside of 11.18%. The high price target for MDSO is $95.00 and the low price target for MDSO is $78.00. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.77	2.85	2.85	2.77
Ratings Breakdown:	0 Sell Rating(s) 3 Hold Rating(s) 10 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 11 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 11 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 10 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$84.4615	$83.3846	$83.00	$83.5385
Price Target Upside:	11.18% upside	13.51% upside	27.75% upside	27.17% upside

Medidata Solutions (NASDAQ:MDSO) Consensus Price Target History

Price Target History for Medidata Solutions (NASDAQ:MDSO)

Medidata Solutions (NASDAQ:MDSO) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/21/2018	Morgan Stanley	Downgrade	Overweight ➝ Hold	$79.00	High
5/10/2018	Dougherty & Co	Reiterated Rating	Buy ➝ Buy	$79.00 ➝ $89.00	Medium
4/20/2018	Needham & Company LLC	Boost Price Target	Buy	$80.00	Medium
2/8/2018	Royal Bank of Canada	Set Price Target	Hold	$82.00	Medium
12/8/2017	Deutsche Bank	Initiated Coverage	Buy ➝ Buy	$78.00	Low
12/1/2017	Wells Fargo	Upgrade	Market Perform ➝ Outperform	$80.00	Low
10/27/2017	SunTrust Banks	Reiterated Rating	Buy	$92.00	N/A
9/17/2017	KeyCorp	Reiterated Rating	Buy	$86.00	Low
8/22/2017	Jefferies Group	Reiterated Rating	Hold	$78.00	Medium
7/24/2017	Citigroup	Reiterated Rating	Buy	$94.00 ➝ $95.00	Low
7/18/2017	JPMorgan Chase	Boost Price Target	Overweight	$87.00	High
7/7/2017	Piper Jaffray Companies	Boost Price Target	Overweight	$87.00	High
6/6/2017	Bank of America	Initiated Coverage	Buy ➝ Buy	$85.00	High
12/4/2016	Pacific Crest	Set Price Target	Buy	$65.00	N/A

(Data available from 5/22/2016 forward)

Medidata Solutions (NASDAQ:MDSO) Earnings History and Estimates Chart

Earnings by Quarter for Medidata Solutions (NASDAQ:MDSO)

Medidata Solutions (NASDAQ:MDSO) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.17	$0.17	$0.17
Q2 2018	1	$0.22	$0.22	$0.22

Medidata Solutions (NASDAQ MDSO) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/16/2018		$0.40					N/A
4/19/2018	Q1 2018	$0.35	$0.40	$146.73 million	$149.20 million	View	N/A
2/8/2018	Q4 2017	$0.31	$0.41	$140.65 million	$141.20 million	View	N/A
10/26/2017	Q3 2017	$0.31	$0.33	$141.27 million	$140.08 million	View	N/A
7/18/2017	Q2 2017	$0.28	$0.31	$134.28 million	$137.41 million	View	N/A
4/26/2017	Q1 2017	$0.11	$0.31	$125.90 million	$126.80 million	View	N/A
2/9/2017	Q416	$0.26	$0.33	$124.15 million	$124.50 million	View	Listen
10/25/2016	Q316	$0.26	$0.28	$118.96 million	$120.10 million	View	Listen
7/20/2016	Q216	$0.23	$0.24	$112.39 million	$114.60 million	View	Listen
4/21/2016	Q116	$0.18	$0.25	$103.22 million	$104.20 million	View	Listen
2/10/2016	Q415	$0.24	$0.27	$105.09 million	$98.90 million	View	Listen
10/27/2015	Q315	$0.24	$0.12	$103.49 million	$103.10 million	View	Listen
7/21/2015	Q215	$0.20	$0.22	$97.27 million	$98.10 million	View	Listen
4/23/2015	Q115	$0.02	$0.17	$91.05 million	$92.40 million	View	Listen
2/5/2015	Q414	$0.10	$0.15	$91.12 million	$89.20 million	View	Listen
10/28/2014	Q314	$0.22	$0.20	$87.72 million	$86.00 million	View	N/A
7/29/2014	Q214	$0.07	$0.04	$81.90 million	$83.20 million	View	Listen
4/22/2014	Q114	$0.16	$0.11	$79.50 million	$76.60 million	View	Listen
2/6/2014	Q413	$0.17	$0.23	$73.97 million	$74.60 million	View	Listen
10/24/2013	Q313	$0.33	$0.40	$70.74 million	$70.90 million	View	N/A
7/25/2013	Q2 2013	$0.12	$0.20	$66.71 million	$68.07 million	View	N/A
4/29/2013	Q1 2013	$0.23	$0.35	$61.32 million	$63.30 million	View	N/A
2/21/2013	Q4 2012	$0.28	$0.35	$59.12 million	$58.60 million	View	N/A
10/31/2012		$0.31	$0.29			View	N/A
7/31/2012		$0.23	$0.23			View	N/A
5/1/2012		$0.22	$0.26			View	N/A
3/6/2012		$0.37	$0.37			View	N/A
11/8/2011		$0.34	$0.42			View	N/A
8/9/2011		$0.33	$0.40			View	N/A
5/10/2011		$0.23	$0.21			View	N/A
3/15/2011		$0.26	$0.29			View	N/A
11/9/2010	Q3 2010	$0.06	$0.10			View	N/A
8/12/2010	Q2 2010	$0.04	$0.07			View	N/A
5/13/2010	Q1 2010	$0.03	$0.04			View	N/A
3/4/2010	Q4 2009	$0.04	$0.05			View	N/A
11/12/2009	Q3 2009	($0.01)	$0.03			View	N/A

(Earnings results data provided by Zacks Investment Research)

Medidata Solutions (NASDAQ:MDSO) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Medidata Solutions (NASDAQ MDSO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.70%

Insider Trading History for Medidata Solutions (NASDAQ:MDSO)

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Medidata Solutions (NASDAQ MDSO) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/25/2018	Michael I Otner	EVP	Sell	10,395	$70.05	$728,169.75	74,165
4/19/2018	Rouven Bergmann	CFO	Sell	4,000	$71.50	$286,000.00	93,744
3/19/2018	Rouven Bergmann	CFO	Sell	2,000	$66.30	$132,600.00	94,744
3/12/2018	Tarek Sherif	CEO	Sell	26,836	$70.25	$1,885,229.00
2/20/2018	Rouven Bergmann	CFO	Sell	2,000	$67.47	$134,940.00	82,775
1/24/2018	Rouven Bergmann	CFO	Sell	3,000	$70.00	$210,000.00	84,775
1/19/2018	Rouven Bergmann	CFO	Sell	2,000	$66.46	$132,920.00	87,775
12/19/2017	Rouven Bergmann	CFO	Sell	2,000	$65.95	$131,900.00	89,775
11/30/2017	Carlos Dominguez	Director	Sell	9,066	$66.85	$606,062.10	66,020
11/30/2017	Rouven Bergmann	CFO	Sell	2,000	$65.40	$130,800.00	91,775
11/17/2017	Michael Pray	EVP	Sell	5,944	$70.47	$418,873.68
11/15/2017	Michael L Capone	COO	Sell	5,000	$66.33	$331,650.00
11/6/2017	Robert Taylor	Director	Sell	5,000	$71.39	$356,950.00	49,372
11/2/2017	Michael I Otner	EVP	Sell	10,000	$70.88	$708,800.00	80,674
11/2/2017	Tarek Sherif	CEO	Sell	200,000	$68.76	$13,752,000.00
8/15/2017	Michael L. Capone	COO	Sell	5,000	$74.53	$372,650.00
6/5/2017	Robert Taylor	Director	Sell	5,639	$73.46	$414,240.94	54,372
5/15/2017	Michael L Capone	COO	Sell	5,000	$69.46	$347,300.00	171,754
5/1/2017	Michael I Otner	EVP	Sell	7,500	$66.39	$497,925.00	78,419
4/4/2017	Tarek Sherif	CEO	Sell	2,964	$57.08	$169,185.12	815,356
3/9/2017	Vries Glen Michael De	President	Sell	7,500	$56.05	$420,375.00	934,929
3/2/2017	Tarek Sherif	CEO	Sell	7,500	$57.06	$427,950.00	825,820
2/14/2017	Michael L. Capone	COO	Sell	5,000	$56.14	$280,700.00
1/25/2017	Steven Isaac Hirschfeld	Vice Chairman	Sell	10,000	$50.83	$508,300.00
1/11/2017	Vries Glen Michael De	President	Sell	7,500	$52.44	$393,300.00
1/4/2017	Tarek Sherif	CEO	Sell	7,500	$51.56	$386,700.00
12/21/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	10,000	$51.02	$510,200.00	40,400
12/2/2016	Tarek Sherif	CEO	Sell	7,500	$52.68	$395,100.00	807,080
11/30/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	10,000	$54.87	$548,700.00	50,400
11/16/2016	Eileen Schloss	EVP	Sell	3,831	$56.60	$216,834.60	33,561
11/16/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	156	$57.85	$9,024.60	60,556
11/9/2016	Vries Glen Michael De	President	Sell	7,500	$50.85	$381,375.00	939,017
11/2/2016	Tarek Sherif	CEO	Sell	7,500	$46.70	$350,250.00	814,580
10/26/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	10,000	$48.50	$485,000.00	60,400
10/25/2016	Michael I Otner	EVP	Sell	7,331	$53.87	$394,920.97	86,378
10/11/2016	Vries Glen Michael De	President	Sell	7,500	$54.72	$410,400.00	942,653
10/4/2016	Tarek Sherif	CEO	Sell	7,500	$54.86	$411,450.00	829,580
9/28/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	10,000	$56.17	$561,700.00	70,400
9/12/2016	Vries Glen Michael De	President	Sell	7,500	$53.70	$402,750.00	950,153
9/7/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	10,000	$55.85	$558,500.00	90,400
9/2/2016	Tarek Sherif	CEO	Sell	7,500	$54.33	$407,475.00	837,580
8/31/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	10,000	$54.11	$541,100.00
8/29/2016	Michael I Otner	EVP	Sell	6,006	$53.92	$323,843.52	93,709
8/9/2016	Vries Glen Michael De	President	Sell	7,500	$54.39	$407,925.00	982,653
8/2/2016	Tarek Sherif	CEO	Sell	7,500	$52.97	$397,275.00	870,080
7/29/2016	Eileen Schloss	EVP	Sell	2,083	$53.04	$110,482.32	29,013
7/27/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	10,000	$52.77	$527,700.00	90,400
7/26/2016	Eileen Schloss	EVP	Sell	10,644	$52.82	$562,216.08	25,765
7/22/2016	Michael I. Otner	EVP	Sell	7,500	$51.27	$384,525.00
7/20/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	20,825	$52.89	$1,101,434.25	111,225
7/12/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	10,000	$49.85	$498,500.00	110,400
7/12/2016	Tarek Sherif	CEO	Sell	22,036	$49.24	$1,085,052.64	877,580
7/12/2016	Vries Glen Michael De	President	Sell	32,500	$49.25	$1,600,625.00	1,015,153
7/5/2016	Tarek Sherif	CEO	Sell	7,500	$46.35	$347,625.00
6/29/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	10,000	$45.66	$456,600.00	100,166
6/9/2016	Vries Glen Michael De	President	Sell	7,500	$47.66	$357,450.00	1,022,453
6/2/2016	Tarek Sherif	CEO	Sell	7,500	$45.90	$344,250.00	906,849
5/31/2016	Robert Taylor	Director	Sell	3,752	$45.03	$168,952.56	50,742
5/25/2016	Neil M Kurtz	Director	Sell	5,937	$44.95	$266,868.15	110,762
5/25/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	10,000	$44.94	$449,400.00	110,166
5/25/2016	Tarek Sherif	CEO	Sell	7,500	$45.00	$337,500.00	914,349
4/27/2016	Steven Isaac Hirschfeld	Vice Chairman	Sell	10,000	$45.09	$450,900.00	125,867
4/25/2016	Eileen Schloss	EVP	Sell	68,717	$46.53	$3,197,402.01	22,361
4/25/2016	Vries Glen Michael De	President	Sell	7,500	$46.36	$347,700.00	1,086,425
2/16/2016	Lee Shapiro	Director	Buy	1,500	$33.45	$50,175.00	30,131
7/21/2015	Steven Isaac Hirschfeld	Insider	Sell	5,293	$61.00	$322,873.00
7/20/2015	Steven Isaac Hirschfeld	Insider	Sell	4,908	$59.00	$289,572.00
5/29/2015	Eileen Schloss	EVP	Sell	2,084	$57.10	$118,996.40
5/29/2015	Robert Taylor	Director	Sell	5,048	$56.81	$286,776.88
5/14/2015	Steven Isaac Hirschfeld	Insider	Sell	22,153	$53.36	$1,182,084.08
4/29/2015	Eileen Schloss	EVP	Sell	4,166	$55.20	$229,963.20
4/28/2015	Cory Douglas	CFO	Sell	12,333	$55.29	$681,891.57
3/23/2015	Vries Glen Michael De	President	Sell	20,000	$49.89	$997,800.00
2/18/2015	Eileen Schloss	EVP	Sell	12,065	$46.98	$566,813.70
2/17/2015	Michael I Otner	EVP	Sell	11,010	$46.75	$514,717.50
2/10/2015	Bryan Charles Spielman	EVP	Sell	5,851	$45.00	$263,295.00
2/10/2015	Robert Taylor	Director	Sell	28,672	$44.07	$1,263,575.04
2/9/2015	Cory Douglas	CFO	Sell	38,000	$44.24	$1,681,120.00
2/9/2015	Eileen Schloss	EVP	Sell	12,499	$44.43	$555,330.57
12/4/2014	Steven Isaac Hirschfeld	Insider	Sell	22,075	$42.53	$938,849.75
11/19/2014	Michael L Capone	COO	Buy	2,400	$40.01	$96,024.00
10/3/2014	Tarek Sherif	CEO	Sell	20,000	$45.30	$906,000.00
9/9/2014	Vries Glen Michael De	President	Sell	20,000	$48.51	$970,200.00
8/26/2014	Bryan Charles Spielman	EVP	Sell	20,000	$47.73	$954,600.00
8/22/2014	Steven Isaac Hirschfeld	EVP	Sell	23,801	$44.00	$1,047,244.00
8/7/2014	Michael I Otner	EVP	Sell	10,000	$44.84	$448,400.00
8/5/2014	Tarek Sherif	CEO	Sell	20,000	$44.81	$896,200.00
8/4/2014	Bryan Charles Spielman	EVP	Sell	2,261	$45.00	$101,745.00
7/8/2014	Vries Glen Michael De	President	Sell	20,000	$40.13	$802,600.00
7/7/2014	Tarek Sherif	CEO	Sell	20,000	$43.20	$864,000.00
6/17/2014	Tarek Sherif	CEO	Sell	19,818	$40.27	$798,070.86
6/17/2014	Vries Glen Michael De	President	Sell	20,000	$40.26	$805,200.00
4/8/2014	Vries Glen Michael De	President	Sell	20,000	$47.71	$954,200.00	1,077,574
4/3/2014	Tarek Sherif	CEO	Sell	20,000	$55.05	$1,101,000.00	920,626
2/19/2014	Eileen Schloss	EVP	Sell	16,847	$60.76	$1,023,623.72	45,363
2/18/2014	Steven Isaac Hirschfeld	EVP	Sell	17,000	$60.03	$1,020,510.00	108,238
2/11/2014	Vries Glen Michael De	President	Sell	20,000	$54.40	$1,088,000.00	1,156,970
1/14/2014	Vries Glen Michael De	President	Sell	20,000	$59.35	$1,187,000.00	972,666
1/6/2014	Tarek Sherif	CEO	Sell	20,000	$59.44	$1,188,800.00	812,718
12/13/2013	Steven Isaac Hirschfeld	EVP	Sell	10,000	$113.01	$1,130,100.00	38,451
12/11/2013	Steven Isaac Hirschfeld	EVP	Sell	10,000	$116.59	$1,165,900.00	38,451
12/10/2013	Vries Glen Michael De	President	Sell	10,000	$116.39	$1,163,900.00	517,459
12/6/2013	Tarek Sherif	CEO	Sell	53,290	$118.08	$6,292,483.20	437,485
12/6/2013	Vries Glen Michael De	President	Sell	43,289	$118.11	$5,112,863.79	528,659
11/12/2013	Cory Douglas	CFO	Sell	10,000	$108.08	$1,080,800.00	39,293
11/1/2013	Cory Douglas	CFO	Sell	30,000	$109.59	$3,287,700.00
10/29/2013	Eileen Schloss	EVP	Sell	12,500	$116.08	$1,451,000.00
10/28/2013	Lee Shapiro	Director	Sell	3,800	$117.48	$446,424.00
10/28/2013	Michael I Otner	EVP	Sell	5,071	$117.45	$595,588.95
9/16/2013	Bryan Charles Spielman	EVP	Sell	3,905	$99.47	$388,430.35	19,171
8/1/2013	Michael I Otner	EVP	Sell	2,500	$92.16	$230,400.00
7/26/2013	Vries Glen Michael De	President	Sell	56,547	$90.08	$5,093,753.76
7/25/2013	Bryan Charles Spielman	EVP	Sell	4,145	$86.66	$359,205.70
7/1/2013	Bryan Charles Spielman	EVP	Sell	3,950	$78.78	$311,181.00
6/28/2013	Steven Isaac Hirschfeld	EVP	Sell	5,486	$76.84	$421,544.24
6/5/2013	Steven Isaac Hirschfeld	EVP	Sell	5,189	$68.84	$357,210.76
5/22/2013	Steven Isaac Hirschfeld	EVP	Sell	10,711	$67.60	$724,063.60
5/10/2013	Robert Taylor	Director	Sell	4,533	$70.31	$318,715.23
5/1/2013	Neil M Kurtz	Director	Sell	5,910	$66.02	$390,178.20
2/25/2013	Lineene Norris Krasnow	EVP	Sell	18,690	$50.39	$941,789.10
2/22/2013	Vries Glen Michael De	President	Sell	56,547	$50.20	$2,838,659.40
10/4/2012	Tarek Sherif	CEO	Sell	40,000	$39.47	$1,578,800.00
10/3/2012	Vries Glen Michael De	President	Sell	27,604	$39.77	$1,097,811.08

(Data available from 1/1/2013 forward)

Medidata Solutions (NASDAQ MDSO) News Headlines

Source:

Date	Headline
	Medidata Solutions (MDSO) Cut to Hold at Morgan Stanley www.americanbankingnews.com - May 21 at 11:05 AM
	Medidata Solutions -1.3% on analyst downgrade seekingalpha.com - May 21 at 8:56 AM
	Medidata to Showcase Rave Omics with Biomarker Discovery in Oncology Research at Industry Expert Theater Presentation finance.yahoo.com - May 21 at 8:56 AM
	Brokerages Anticipate Medidata Solutions (MDSO) to Announce $0.40 EPS www.americanbankingnews.com - May 20 at 7:25 AM
	Should You Be Tempted To Sell Medidata Solutions Inc (NASDAQ:MDSO) At Its Current PE Ratio? finance.yahoo.com - May 19 at 8:56 AM
	Medidata Solutions (MDSO) Given Consensus Recommendation of "Buy" by Brokerages www.americanbankingnews.com - May 17 at 3:31 PM
	PhaseBio Pharma Becomes Medidata’s 1,000th Customer, Making Company First in Industry to Achieve This Milestone finance.yahoo.com - May 17 at 9:16 AM
	Dougherty & Co Reaffirms "Buy" Rating for Medidata Solutions (MDSO) www.americanbankingnews.com - May 10 at 5:58 PM
	Medidata to Present at the 46th Annual J.P. Morgan Global Technology, Media and Communication Conference finance.yahoo.com - May 10 at 9:17 AM
	Medidata Solutions (MDSO) Upgraded to "Buy" by BidaskClub www.americanbankingnews.com - May 5 at 12:11 AM
	Medidata’s Melinda Pautsch Named a “Rising Star” by the Healthcare Businesswomen’s Association finance.yahoo.com - May 4 at 9:00 AM
	Medidata Solutions (MDSO) Expected to Announce Quarterly Sales of $156.27 Million www.americanbankingnews.com - May 4 at 2:14 AM
	Medidata to Present at Jefferies 2018 Global Technology Conference finance.yahoo.com - May 3 at 9:01 AM
	Analysts Expect Medidata Solutions (MDSO) to Post $0.40 Earnings Per Share www.americanbankingnews.com - May 2 at 7:12 PM
	Global eClinical Solutions Market to 2024: Market to Grow at a CAGR of 11.9% - Key Players are Medidata Solutions, Oracle, Bioclinica, CRF Health, Merge Healthcare www.prnewswire.com - May 1 at 8:28 PM
	Medidata Solutions (MDSO) EVP Michael I. Otner Sells 10,395 Shares www.americanbankingnews.com - April 27 at 7:08 PM
	Medidata Edge Strategic Monitoring Wins “Best Sponsor-Focused Technological Development” at CARE Awards 2018 finance.yahoo.com - April 27 at 9:33 AM
	Medidata Solutions (MDSO) Lowered to Hold at Zacks Investment Research www.americanbankingnews.com - April 26 at 10:08 AM
	FY2018 Earnings Forecast for Medidata Solutions Issued By Dougherty & Co (MDSO) www.americanbankingnews.com - April 25 at 9:34 AM
	Equities Analysts Offer Predictions for Medidata Solutions' Q2 2018 Earnings (MDSO) www.americanbankingnews.com - April 24 at 7:54 AM
	Medidata Solutions (MDSO) Given Average Recommendation of "Buy" by Brokerages www.americanbankingnews.com - April 22 at 3:29 PM
	Medidata Solutions (MDSO) CFO Sells $286,000.00 in Stock www.americanbankingnews.com - April 20 at 7:40 PM
	Medidata Solutions (MDSO) Price Target Raised to $80.00 www.americanbankingnews.com - April 20 at 11:32 AM
	Is Medidata Solutions Inc (NASDAQ:MDSO) Undervalued? finance.yahoo.com - April 19 at 4:56 PM
	Medidata Solutions (MDSO) Releases Earnings Results, Beats Estimates By $0.05 EPS www.americanbankingnews.com - April 19 at 9:11 AM
	Medidata Reaffirms 2018 Outlook - Quick Facts www.nasdaq.com - April 19 at 9:03 AM
	Medidata Solutions beats by $0.05, beats on revenue seekingalpha.com - April 19 at 9:03 AM
	Medidata Reports First Quarter 2018 Results finance.yahoo.com - April 19 at 9:03 AM
	Medidata: 1Q Earnings Snapshot finance.yahoo.com - April 19 at 9:03 AM
	Medidata Solutions (MDSO) Upgraded by Zacks Investment Research to "Buy" www.americanbankingnews.com - April 17 at 8:17 AM
	Medidata Solutions (MDSO) Set to Announce Earnings on Tuesday www.americanbankingnews.com - April 17 at 3:28 AM
	Analysts Anticipate Medidata Solutions (MDSO) Will Announce Quarterly Sales of $147.63 Million www.americanbankingnews.com - April 17 at 2:38 AM
	Medidata Solutions (MDSO) Downgraded by BidaskClub to "Hold" www.americanbankingnews.com - April 16 at 8:06 PM
	Zacks: Brokerages Expect Medidata Solutions (MDSO) to Announce $0.35 EPS www.americanbankingnews.com - April 15 at 7:17 PM
	Cross-Selling Can Drive Meaningful Growth For Medidata Solutions seekingalpha.com - April 13 at 4:48 PM
	Medidata Solutions (MDSO) Upgraded to "Hold" at ValuEngine www.americanbankingnews.com - April 12 at 10:18 PM
	Medidata Solutions (MDSO) Lowered to "Sell" at Zacks Investment Research www.americanbankingnews.com - April 12 at 10:19 AM
	Medidata Solutions (MDSO) Earns Hold Rating from Jefferies Group www.americanbankingnews.com - April 9 at 11:59 PM
	Medidata Schedules First Quarter Earnings Conference Call for April 19, 2018 www.businesswire.com - April 6 at 9:24 AM
	Australia NHMRC Clinical Trials Centre Partners with Medidata to Digitize Cancer Research finance.yahoo.com - April 4 at 9:12 AM
	Zacks Investment Research Lowers Medidata Solutions (MDSO) to Sell www.americanbankingnews.com - April 2 at 10:44 AM
	Medidata Solutions (MDSO) Research Coverage Started at Dougherty & Co www.americanbankingnews.com - April 1 at 11:58 PM
	Medidata Solutions (MDSO) Upgraded by Zacks Investment Research to "Hold" www.americanbankingnews.com - March 31 at 4:56 PM
	Zacks: Brokerages Anticipate Medidata Solutions Inc (MDSO) to Post $0.35 Earnings Per Share www.americanbankingnews.com - March 29 at 9:14 PM
	Medidata Solutions Inc (MDSO) Receives Consensus Recommendation of "Buy" from Analysts www.americanbankingnews.com - March 28 at 3:32 PM
	Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives finance.yahoo.com - March 28 at 9:19 AM
	BidaskClub Upgrades Medidata Solutions (MDSO) to Hold www.americanbankingnews.com - March 28 at 12:00 AM
	Medidata Solutions Inc (MDSO) CFO Rouven Bergmann Sells 2,000 Shares www.americanbankingnews.com - March 21 at 7:33 PM
	Medidata Solutions (MDSO) Lowered to "Sell" at ValuEngine www.americanbankingnews.com - March 17 at 11:59 AM
	Free Post Earnings Research Report: Medidata’s Revenue Advanced 13%; Adjusted EPS Surged 24% finance.yahoo.com - March 15 at 8:58 AM

Medidata Solutions (NASDAQ:MDSO) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Medidata Solutions (NASDAQ:MDSO) Income Statement, Balance Sheet and Cash Flow Statement

Medidata Solutions (NASDAQ MDSO) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff